BiotechTube
Home/RyMed Technologies/Todd Adamson
TA

Todd Adamson

Director of Sales

RyMed Technologies

Therapeutic Areas

Infection PreventionVascular Access

RyMed Technologies Pipeline

DrugIndicationPhase
InVision-Plus® Pediatric/NICU LineVascular access safety for pediatric and neonatal patientsCommercial
InVision-Plus® CS (Chlorhexidine Silver)Vascular access safety with antimicrobial impregnationCommercial